Table 6.
CD | UC | IBD_NS | All | |
Age at diagnosis | ||||
0–5 years | 44 (11.1%) | 23 (11.3%) | 19 (30.6%) | 86 (13.0%) |
6–9 years | 139 (35.0%) | 73 (35.8%) | 19 (30.6%) | 231 (34.8%) |
10–13 years | 190 (47.9%) | 92 (45.1%) | 20 (32.3%) | 302 (45.6%) |
>14 years | 24 (6.0%) | 16 (7.8%) | 4 (6.5%) | 44 (6.6%) |
Course during last year | ||||
Stable remission | 161 (40.4%) | 85 (41.3%) | 29 (46.0%) | 275 (41.2%) |
One relapse | 116 (29.1%) | 49 (23.8%) | 20 (31.7%) | 185 (27.7%) |
More relapses/chronically active | 122 (30.6%) | 72 (35.0%) | 14 (22.2%) | 208 (31.1%) |
Current health status | ||||
Good | 261 (65.1%) | 137 (66.5%) | 40 (63.5%) | 438 (65.4%) |
Moderate | 115 (28.7%) | 46 (22.3%) | 19 (30.2%) | 180 (26.9%) |
Poor | 25 (6.2%) | 23 (11.2%) | 4 (6.3%) | 52 (7.8%) |
Disease duration | ||||
<1 years | 57 (14.3%) | 29 (14.1%) | 11 (17.5%) | 97 (14.5%) |
1 to <2 years | 61 (15.3%) | 29 (14,1%) | 8 (12.7%) | 98 (14.7%) |
2 to <5 years | 167 (41.9%) | 84 (41.0%) | 17 (27.0%) | 268 (40.2%) |
5 years+ | 114 (8.5%) | 63 (30.7%) | 27 (42.9%) | 204 (30.7%) |
Resecting surgery | ||||
Has had surgery | 31 (7.7%) | 12 (5.8%) | 2 (3.2%) | 45 (6.7%) |
Therapy | ||||
Ever had corticosteroids | 284 (83.8%) | 153 (86.9%) | 36 (69.2%) | 473 (83.4%) |
Ever had biological | 131 (32.4%) | 31 (14.9%) | 10 (15.9%) | 172 (25.5%) |
Ever had immunomodulators | 334 (82.7%) | 137 (65.9%) | 27 (57.1%) | 498 (74.1%) |
Total | 404 | 208 | 63 | 675 |